This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Oral Presentation of The First Phase I Clinical Trial of AT278 at ATTD
Oral Presentation: AT278 (U500) – PK/PD and safety of rapid-acting concentrated insulin aspart
Presenting Author: Dr Eva Svehlikova
Session: Oral Presentations Session 2
Date and Time: Thursday, 28 April 2022, at 17:20 Central European Time